Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07613931 · ClinicalTrials.gov registry record · Early Phase 1
Evaluate Advanced Pneumatic Compression Device With Revised Compression Programming for Lymphedema Treatment
A Early Phase 1 study, sponsored by Tactile Medical.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
NCT07613931 is a Early Phase 1 study that is actively recruiting participants, run by Tactile Medical. The registered enrollment target is 5 participants.
The verdict
NCT07613931, a Early Phase 1 study, is actively recruiting participants, sponsored by Tactile Medical.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The goal of this pilot study is to learn if a revised method of compression improves lymphatic function compared to the current method of compression. The main questions: • Does the revised method of compression improve lymph movement and lymphatic propulsion?
Interventions
- DEVICE Advanced pneumatic compression device (APCD)
- DEVICE Advanced pneumatic compression device (APCD) with revised compression programming
- DRUG Indocyanine Green (IC-Green)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2026-07 |
| Est. Completion | 2026-09 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07613931
The ClinicalTrials.gov registry entry for NCT07613931 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tactile Medical, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Advanced pneumatic compression device (APCD) is the first listed.
NCT07613931 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07613931 about?
NCT07613931 is a clinical study titled "Evaluate Advanced Pneumatic Compression Device With Revised Compression Programming for Lymphedema Treatment". The goal of this pilot study is to learn if a revised method of compression improves lymphatic function compared to the current method of compression. The main questions: • Does the revised method of compression improve lymph movement and lymphatic propulsion?
What is the current status of trial NCT07613931?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2026-07. Estimated completion is 2026-09.
What interventions are being tested in trial NCT07613931?
The interventions under investigation include: Advanced pneumatic compression device (APCD) (DEVICE), Advanced pneumatic compression device (APCD) with revised compression programming (DEVICE), Indocyanine Green (IC-Green) (DRUG).
Who is sponsoring clinical trial NCT07613931?
This trial is sponsored by Tactile Medical, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.